Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
TASK ORDER NO. 75N94020F00001 TITLE: CHEMICAL SCREENING AND OPTIMIZATION FACILITY - "SCALABLE QUANTITIES OF ACTIVE PHARMACEUTICAL INGREDIENTS"Department of Health and Human Services$315.6K obligationsEnds Sep 23, 2022
HHSN275201500002I - BIOLOGICAL TESTING FACILITY TASK ORDER 16: CLINICAL MANUFACTURING, FORMULATION DEVELOPMENT AND STABILITY TESTING - SRI INTERNATIONAL - CAN 8030701Department of Health and Human Services$834.4K obligationsEnds Mar 19, 2025
75N9420D00003 - BIOLOGICAL TESTING FACILITY: TASK ORDER 2: PRECLINICAL - SRI INTERNATIONAL - CAN 8030701Department of Health and Human Services$2.1M obligationsEnds Sep 3, 2022
CONTRACT: HHSN275201800007I - CHEMICAL SCREENING AND OPTIMIZATION FACILITY TASK ORDER: 75N94021F0000 (TASK ORDER 7)- HIGH THROUGHPUT SCREENING POP: 5/28/21 - 9/30/23Department of Health and Human Services$859.2K obligationsEnds Sep 30, 2024
75N9420D00003 - BIOLOGICAL TESTING FACILITY, TASK ORDER 5: WEBSITE - SRI INTERNATIONAL - CAN 8030701Department of Health and Human Services$196.0K obligationsEnds Jan 6, 2023
ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTINGDepartment of Health and Human Services$11.2M obligationsEnds Sep 29, 2026
75N94020D00003-BIOLOGICAL TESTING FACILITY (BTF): TASK ORDER 20 - "PRECLINICAL DEVELOPMENT OF CONTRACEPTIVE PRODUCTS".Department of Health and Human Services$1.0M obligationsEnds Sep 26, 2027
NICHD: R&D: ANDROGENIC, ANABOLIC, AND PRECLINICAL SAFETY STUDIES: NON-SEVERABLEDepartment of Health and Human Services$323.9K obligationsEnds Jul 31, 2027
NICHD: R&D: BIOLOGICAL TESTING FACILITY - DRUG PRODUCT MANUFACTURE OF ONGOING CLINICAL DEVELOPMENT: NON-SEVERABLEDepartment of Health and Human Services$349.6K obligationsEnds Jul 31, 2028
PHARMACOKINETICS OF LONG-ACTING PREPARATIONS OF ANTITUBERCULAR DRUGS IN RODENTSDepartment of Health and Human Services$830.6K obligationsEnds Jan 31, 2027
NICHD: R&D: PRECLINICAL, MANUFACTURING, AND STABILITY STUDIES: NON-SEVERABLEDepartment of Health and Human Services$1.5M obligationsEnds May 31, 2028
ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING OF CANDIDATE MEDICAL COUNTERMEASURES (MCMS)Department of Health and Human Services$16.2M obligationsEnds Sep 29, 2027
NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONSDepartment of Health and Human Services$5.1M obligationsEnds Jul 20, 2027
ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTINGDepartment of Health and Human Services$3.4M obligationsEnds Sep 29, 2027
ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTINGDepartment of Health and Human Services$12.1M obligationsEnds Sep 29, 2027
DECORPORATION MCM PHASE 1 CLINICAL SAFETY STUDYDepartment of Health and Human Services$9.8M obligationsEnds Apr 30, 2027
GLP TOXICOLOGY STUDY FOR ADJUVANTED HIV-1 IMMUNOGEN VACCINE CANDIDATESDepartment of Health and Human Services$1.4M obligationsEnds Aug 1, 2028
TASK ORDER B-1, ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING OF CANDIDATE MCMSDepartment of Health and Human Services$14.5M obligationsEnds Dec 30, 2026
75N9420D00003 - BIOLOGICAL TESTING FACILITY: TASK ORDER 1: ADMINISTRATIVE/MANAGEMENT - SRI INTERNATIONALDepartment of Health and Human Services$2.6M obligationsEnds Sep 3, 2025
NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONSDepartment of Health and Human Services$6.2M obligationsEnds Jul 20, 2027
BIOLOGICAL TESTING FACILITY - "CONTRACEPTIVE DRUG AND INTRAVAGINAL CONTRACEPTIVE DEVICE EVALUATION"Department of Health and Human Services$696.9K obligationsEnds Mar 21, 2022
THE OBJECTIVE OF THIS TASK ORDER IS TO OBTAIN SERVICES FOR THE DEVELOPMENT OF CONTRACEPTIVE PRODUCTS INTENDED FOR NON-SYSTEMIC DELIVERY TO DETERMINE, AS APPROPRIATE, THE…Department of Health and Human Services$1.4M obligationsEnds Mar 20, 2026
BIOLOGICAL TESTING FACILITY (BTF): TASK ORDER 15- "NONCLINICAL FEMALE CONTRACEPTIVE DEVELOPMENT SERVICES". THE OBJECTIVE OF THIS TASK ORDER IS TO OBTAIN NONCLINICAL FEMALE…Department of Health and Human Services$1.1M obligationsEnds Sep 21, 2024
DEVELOPMENT OF A NOVEL PLASMA PROTEIN BIOMARKER PANEL FOR A RADIATION/NUCLEAR TRIAGE BIODOSIMETRY DEVICE (RAPID RAD DX)Department of Health and Human Services$2.1M obligationsEnds Apr 11, 2025
TAS::75 0872::TAS SMARTT (11-8470187)Department of Health and Human Services$6.8M obligationsEnds Sep 11, 2018